Furthermore, we demonstrated that MSC‐induced NK resistance in cancer cells was related to an intercellular loop of cGAS‐STING‐IFNβ‐HLA signaling, consistent with the findings of clinical tumor sample analysis. The gene discussed is STING1; the disease is neoplasm.